Contact Us | 1-844-394-7663

Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

 

WEBINAR:


My Journey with Prostate Cancer:

Cal Ripken Jr.

 


Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.
Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with Hall of Famer and baseball’s all-time “Iron Man”, Cal Ripken Jr. He is a 2007 Hall of Famer, 19-time All-Star, and two-time MVP. This year marks 25 years since Ripken played in his 2,131st consecutive game, eclipsing the thought to be unbreakable record of 2,130 set by the legendary Lou Gehrig. He went on to play an additional 501 games before finishing his baseball career with 2,632 consecutive games. Recently the 21-year Major League veteran divulged that earlier this year he was diagnosed with and successfully treated for prostate cancer.

The ExoDx Prostate (EPI) test played an important role in the management of Cal’s prostate cancer and he would like to share his journey with you in this webinar.

We believe Cal’s story is powerful and compelling and hope you will join us.


Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.